A novolimus-eluting stent was implanted in a total of 15 patients. Diabetes was detected in 47% of the cohort. At 4-month angiographic followup there was in-stent late lumen loss (0.15±0.29 mm) by QCA and % volume obstruction (2.6±2.6) by IVUS. The angiographic in-stent late lumen loss results at eight months were 0.31±0.25mm and % volume obstruction by IVUS was 6.0±4.4%. Late ISA and MACE was not evidenced at 9 months. Read more
From February 2005 until December 2007, 175 patients were treated with this technique in seven European Centres by highly experienced operators; in 84 (48%) as primary strategy, in 41 (23.5%) immediately after antegrade failure and in 50 (28.5%) as a repeat procedure after previous antegrade failure. The mean occlusion duration was 50.8 months (determined in 32% of patients). The target vessel was: LAD 21%, LCX 6.3%, RCA 71.4%. Epicardial collaterals were accessed in 20.6% and septal in 79.4% of the patients. Overall success rate was 83.4%. Read more
This two year follow-up of the randomised PASSION trail was performed to assess the long-term effects of paclitaxeleluting stents (PES) compared with bare-metal stents (BMS) in patients who had undergone primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI). The PASSION trial did not show significant clinical improvement after primary PCI with PES versus BMS in 619 patients with STEMI. There was no significant difference between groups in the incidence of stent thrombosis. Read more
The Custom NX® 36 drug eluting stent (DES) system is designed to treat coronary lesions via in situ stent length customisation. Procedural success was 93%. There were a total of three MACEs reported from enrolment through two year follow-up. In-hospital MACE rate was 2/30, with events in two patients presenting post-procedural non-Q-wave myocardial infarctions without further sequelae. At five months, one patient who had crossed over to PTCA required CABG surgery. One non-cardiac death was reported between one and two year follow-up. There was no in-stent restenosis. Read more
Among the regular online ahead-of-print publications, the Editorial Board is pleased to highlight the following major paper from Alec Vahanian and Ottavio Alfieri et al. This position statement on transcatheter valve implantation for patients with aortic stenosis is a simultaneous publication in EuroIntervention, the European Heart Journal and the European Journal of Cardiothoracic Surgery. Other Ahead of Print publications can be found here Read more
For the first time this year, a dedicated EuroIntervention @ EuroPCR session took place with six presentations selected by a special panel of Editorial Board members from the Journal. Awards went to Emanuele Meliga, Lutz Buellesfeld, Mark Patterson, Joachim Schofer, George Sianos, Victor Legrand.
Highlights Discover the pick of the editors.
Content The subject matter of the current issue (in a quick glance).
Editorial Commentaries and opinions from esteemed peers.
EuroIntervention focus on 
For the first time this year, a dedicated EuroIntervention @ EuroPCR session took place with six presentations selected by a special panel of Editorial Board members from the Journal. Awards went to 
Highlights